We are live on ! Find out more
TERN

Terns Pharmaceuticals
TERN

Delisted

TERN was delisted on the 4th of May, 2026.

Back to rankings

78 hedge funds and large institutions have $630M invested in Terns Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 14

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

25% more capital invested

Capital invested by funds: $505M → $630M (+$125M)

20% more funds holding

Funds holding: 65 → 78 (+13)

9.78% less ownership

Funds ownership: 103.68% → 93.9% (-9.8%)

Holders
78
Holders Change
+13
Holders Change %
+20%
% of All Funds
1.24%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.11%
New
27
Increased
26
Reduced
15
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$19.1M
2
PA
Perceptive Advisors
New York
+$12.9M
3
Franklin Resources
Franklin Resources
California
+$6.76M
4
Invesco
Invesco
Georgia
+$5.49M
5
BlackRock
BlackRock
New York
+$3.83M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$10.2M
2
DM
Deerfield Management
New York
-$7.57M
3
PVI
Pura Vida Investments
New York
-$6.16M
4
AC
Armistice Capital
New York
-$5.7M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
76
Lindbrook Capital
California
$1.54K +$1.24K +130 New
S
77
SignatureFD
Georgia
$1.22K +$984 +103 New
BAM
78
Belpointe Asset Management
Nevada
$1.18K +$956 +100 New
ACM
79
Aquatic Capital Management
Illinois
$1K +$956 +100 New
RI
80
RTW Investments
New York
– -$10.2M -1,000,000 Closed
PVI
81
Pura Vida Investments
New York
– -$6.16M -605,079 Closed
AC
82
Armistice Capital
New York
– -$5.7M -560,000 Closed
Bank of Montreal
83
Bank of Montreal
Ontario, Canada
– -$1.98M -194,100 Closed
ECM
84
Endurant Capital Management
California
– -$1.38M -135,994 Closed
MIM
85
Monashee Investment Management
Massachusetts
– -$1.25M -122,500 Closed
Walleye Capital
86
Walleye Capital
New York
– -$749K -73,611 Closed
ACM
87
Altium Capital Management
New York
– -$713K -70,000 Closed
HF
88
HRT Financial
New York
– -$357K -35,090 Closed
Acadian Asset Management
89
Acadian Asset Management
Massachusetts
– -$229K -22,599 Closed
CCM
90
CAAS Capital Management
New York
– -$204K -20,000 Closed
DTL
91
Dynamic Technology Lab
Singapore
– -$160K -15,709 Closed
RJA
92
Raymond James & Associates
Florida
– -$127K -12,488 Closed
1 2 3
4

TERN Hedge Fund Activity: Q1 2023 in Review

78 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Terns Pharmaceuticals (TERN) for Q1 2023, worth a combined $630M — up 25% from $505M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TERN positions and 14 closed out — a net gain of 13 holders — while 26 added to existing stakes and 15 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $19.1M. The largest seller was RTW Investments, exiting entirely with an estimated $10.2M sold.

  • 78 institutional investors held Terns Pharmaceuticals (TERN) as of Q1 2023, up from 65 in Q4 2022.
  • Funds reported $630M of Terns Pharmaceuticals stock for Q1 2023, up 25% quarter-over-quarter.
  • 27 funds opened new Terns Pharmaceuticals positions in Q1 2023 and 14 closed out, a net change of +13 holders.
  • The largest Terns Pharmaceuticals buyer in Q1 2023 was Braidwell, an estimated $19.1M added.
  • The largest Terns Pharmaceuticals seller in Q1 2023 was RTW Investments, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2023.